IndiaOne Finance - Company Dashboard

Governance Classic Home

Aarey Drugs & Pharmaceuticals LtdPharmaceuticalsINE198H01019Standalone₹102.49+1.17 (+1.15%)Jun-26

Valuation

Market Cap₹290.60 Cr

TTM PE69.72x

Forward PE69.25x

PEG-9.23

Book Value₹53.05

P/B1.93x

TTM EPS₹1.47

Fwd EPS₹1.48

TTM Revenue₹414.69 Cr

TTM PAT₹4.88 Cr

TTM EBITDA₹6.80 Cr

TTM EBIT₹3.58 Cr

Last Qtr PAT₹1.02 Cr

Last Qtr EBITDA₹1.33 Cr

Last Qtr EBIT₹0.48 Cr

Profitability

ROE3.24%

ROCE5.00%

TTM NPM1.18%

TTM EBITDA %1.64%

Curr OPM2.20%

Last OPM0.83%

Curr NPM—

Last NPM—

Curr EPS₹0.36

Last EPS₹0.55

Balance sheet

Equity₹28.45 Cr

Reserve₹121.97 Cr

Total Debt₹49.96 Cr

D/E0.33x

Interest %163.73%

Curr Interest₹1.67 Cr

Price / range

Close₹102.49

vs 52W High-0.98%

vs 52W Low+103.35%

MA50—

MA200—

Returns

1D+1.15%

1W+3.29%

1M+24.28%

3M+22.77%

6M+41.29%

1Y+37.29%

2Y+48.54%

3Y+116.63%

5Y+177.00%

Diwali+51.50%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	148.17	3.58%
DIVISLAB	9375.00	₹2.49L Cr	84.62	17.55%
TORNTPHARM	4840.00	₹1.84L Cr	78.80	25.43%
ZYDUSLIFE	1160.00	₹1.16L Cr	33.21	12.96%
CIPLA	1394.50	₹1.13L Cr	36.64	8.93%
LAURUSLABS	1954.00	₹1.06L Cr	120.92	16.46%
AUROPHARMA	1734.00	₹99.77K Cr	38.79	6.84%
DRREDDY	1185.00	₹98.91K Cr	148.68	1.75%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	44.63-56.3%	189.47	96.43	84.16	102.21	472.27
Other Income	1.72	-0.43	4.18	0.79	1.55	6.10
Total Income	46.34-55.3%	189.04	100.61	84.96	103.76	478.37
Interest	1.67	1.78	0.92	1.26	1.04	5
Expenditure	-45.82+55.1%	-187.76	-99.69	-83.47	-102.03	-472.95
PBDT	0	0	0	0	0	0
EBITDA	1.33-22.2%	4.34	-1.51	2.64	1.71	7.17
Depreciation	-0.85	-0.85	-0.83	-0.69	-0.49	-2.85
EBIT	0.48-60.7%	3.49	-2.34	1.95	1.22	4.32
PBT	0.52-69.9%	1.28	0.92	1.48	1.73	5.41
Tax	0.51	0.28	0.35	-0.46	-0.36	-1.45
Equity	28.45	28.45	0	0	28.45	28.45
OPM	1.12	0.68	0.96	1.76	1.67	1.13
Net Profit	1.02-25.5%	1.56	1.28	1.02	1.37	3.97
NPM	2.20	0.83	1.33	1.22	1.32	0.83
EPS	0.36-25.0%	0.55	0.20	0.36	0.48	1.39

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	472.27-0.4%	473.94+19.8%	395.62+533.3%	62.47-87.3%	492.68+41.4%	348.42
Other Income	6.10	9.81	6.97	0.48	2.75	7.02
Total Income	478.37-1.1%	483.76+20.2%	402.58+539.5%	62.95-87.3%	495.43+39.4%	355.43
Expenditure	-472.95+1.0%	-477.65-20.2%	-397.24-538.6%	-62.20+87.2%	-485.40-39.8%	-347.13
Interest	-5	-4.02	-4.38	-0.55	-2	-2.43
PBDT	0	0	0	0	0	0
EBITDA	7.17+218.7%	2.25-49.6%	4.46+191.5%	1.53-86.4%	11.27+142.9%	4.64
Depreciation	-2.85	-1.94	-1.70	-0.71	-1.99	-0.92
EBIT	4.32+1293.5%	0.31-88.8%	2.76+236.6%	0.82-91.2%	9.28+149.5%	3.72
PBT	5.41-11.3%	6.10+14.2%	5.34+612.0%	0.75-92.5%	10.03+20.8%	8.30
Tax	-1.45	-2.08	-0.66	-0.25	-3.48	-1.79
Equity	28.45	280,540.30	0	0	0	0
OPM (%)	1.13	1.26	1.00	1.00	2.00	2.00
Net Profit	3.97-1.2%	4.02-14.1%	4.68+836.0%	0.50-92.4%	6.55+0.6%	6.51
NPM (%)	0.83	0.83	1.00	1.00	1.00	2.00
EPS (Rs)	1.39-57.5%	3.27+77.7%	1.84+868.4%	0.19-93.0%	2.72-2.5%	2.79
CEPS	1.39	3.68	1.84	0.19	2.72	2.79

Metric	FY25-26
Revenue	472.27
Other Income	6.10
Total Income	478.37
Interest	5
Expenditure	-472.95
PBDT	0
EBITDA	7.17
Depreciation	-2.85
EBIT	4.32
PBT	5.41
Tax	-1.45
Equity	28.45
OPM	1.13
Net Profit	3.97
NPM	0.83
EPS	1.39

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25
Revenue	472.27-0.4%	473.94
Other Income	6.10	9.81
Total Income	478.37-1.1%	483.76
Expenditure	-472.95+1.0%	-477.65
Interest	-5	-4.02
PBDT	0	0
EBITDA	7.17+218.7%	2.25
Depreciation	-2.85	-1.94
EBIT	4.32+1293.5%	0.31
PBT	5.41-11.3%	6.10
Tax	-1.45	-2.08
Equity	28.45	280,540.30
OPM (%)	1.13	1.26
Net Profit	3.97-1.2%	4.02
NPM (%)	0.83	0.83
EPS (Rs)	1.39-57.5%	3.27
CEPS	1.39	3.68

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2019	Interim Dividend	0.1	13 Dec 2018

Bonus

Year	Ratio	Ex-Date
2012	1:5	25 Jun 2012

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split